Stay updated on PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.

Latest updates to the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe new screenshot shows a reflowed layout and minor text/label tweaks; core study details such as arms, outcomes, and eligibility criteria appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0 (removes v3.1.0).SummaryDifference5%

- Check47 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.3%

- Check68 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%

- Check76 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several specific location details and drug information have been removed.SummaryDifference3%

Stay in the know with updates to PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.